subject: CHEBI:63635


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: EBV-Related Sarcoma

tested_intervention: unsure


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: temporal arteritis

tested_intervention: yes


subject: CHEBI:71200

object_name: polymyalgia rheumatica


subject: CHEBI:71200

object_name: Safety Issues


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Renal function disorder


subject: CHEBI:85078

object_name: glucose metabolism disease


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Bone marrow depression


subject: UNII:3A189DH42V

object_name: pancytopenia


subject: UNII:3A189DH42V

object_name: Bone marrow hypocellularity


subject: UNII:3A189DH42V

object_name: Fanconi anemia


subject: UNII:3A189DH42V

object_name: Fanconi anemia complementation group A


subject: UNII:3A189DH42V

object_name: telomere syndrome


subject: UNII:3A189DH42V

object_name: inborn error of immunity


subject: UNII:3A189DH42V

object_name: Short telomere length


subject: UNII:3A189DH42V

object_name: Immune Deficiency Disease


subject: UNII:3A189DH42V

object_name: dyskeratosis congenita


subject: UNII:3A189DH42V

object_name: Hoyeraal-Hreidarsson syndrome


subject: UNII:3A189DH42V

object_name: X-Linked Dyskeratosis Congenita


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:60799

subject_name: Esketamine

object_name: Post-Operative Pain


subject: UNII:MC4B01024K

subject_name: CRENOLANIB BESYLATE

object_name: acute myeloid leukemia by FAB classification


subject: UNII:MC4B01024K

object_name: acute myeloid leukemia


subject: UMLS:C3827141

subject_name: Crenolanib Besylate


subject: UMLS:C3827141


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: cystic fibrosis


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Pancreatic Cyst


subject: CHEBI:142708

object_name: abdominal abscess


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:127780

subject_name: Foscarnet

object_name: cytomegalovirus infection


subject: CHEBI:127780

object_name: hematologic disorder


subject: CHEBI:465284

subject_name: Ganciclovir


subject: CHEBI:63632

subject_name: Topotecan

object_name: Advanced cancer


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:177770

subject_name: Ganetespib

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:177770

object_name: Prostate cancer recurrent


subject: CHEBI:177770

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:177770

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:177770

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:177770

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:177770

object_name: prostate adenocarcinoma


subject: CHEBI:15966

subject_name: D-Glutamic Acid

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:15966

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:15966

object_name: Ovarian cancer stage IV


subject: CHEBI:15966

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:15966

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:15966

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:15966

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:15966

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:15966

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:15966

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:15966

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:15966

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:15966

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:15966

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:15966

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:15966

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:29972

subject_name: L-glutamic acid residue

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:29972

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:29972

object_name: Ovarian cancer stage IV


subject: CHEBI:29972

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:29972

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:29972

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:29972

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:29972

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:29972

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:29972

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:29972

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:29972

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:29972

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:29972

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:29972

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:29972

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:16015

subject_name: Glutamic acid

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:16015

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:16015

object_name: Ovarian cancer stage IV


subject: CHEBI:16015

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:16015

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:16015

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:16015

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:16015

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:16015

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:16015

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:16015

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:16015

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:16015

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:16015

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:16015

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:16015

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UNII:92T1Y5X038

subject_name: Florilglutamic acid F-18

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:92T1Y5X038

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Ovarian cancer stage IV


subject: UNII:92T1Y5X038

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIC Ovarian Cancer


subject: UNII:92T1Y5X038

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UNII:92T1Y5X038

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UNII:92T1Y5X038

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:92T1Y5X038

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C4053691

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C4053691

object_name: Ovarian cancer stage IV


subject: UMLS:C4053691

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C4053691

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C4053691

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C4053691

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UMLS:C4053691

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C4053691

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C4053691

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C4053691

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C4053691

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C4053691

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UMLS:C4053691

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UMLS:C4053691

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C5139812

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C5139812

object_name: Ovarian cancer stage IV


subject: UMLS:C5139812

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C5139812

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C5139812

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C5139812

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UMLS:C5139812

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C5139812

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C5139812

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C5139812

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C5139812

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C5139812

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UMLS:C5139812

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UMLS:C5139812

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: melanoma


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: GTOPDB:8313

subject_name: talazoparib

object_name: prostate carcinoma


subject: GTOPDB:8313

object_name: prostate cancer


subject: GTOPDB:8313

object_name: castration-resistant prostate carcinoma


subject: GTOPDB:8313

object_name: prostate neoplasm


subject: GTOPDB:8313

object_name: prostate adenocarcinoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079

object_name: metastatic prostate carcinoma


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UNII:UM2XKY25DH

subject_name: NORELGESTROMIN

object_name: Uses contraception (finding)


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121

object_name: Coronavinae infectious disease


subject: CHEBI:6121

object_name: acute respiratory distress syndrome


subject: CHEBI:6121

object_name: adult acute respiratory distress syndrome


subject: CHEBI:6121

object_name: severe acute respiratory syndrome


subject: CHEBI:7465

subject_name: Naltrexone


subject: CHEBI:7465


subject: CHEBI:7465


subject: CHEBI:7465


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: fibromyalgia


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:15365

subject_name: Aspirin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:15365


subject: CHEBI:174615

object_name: Myelodysplasia, CTCAE


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin

object_name: Stomach cancer


subject: UMLS:C5207052

object_name: gastric cancer


subject: UNII:LR3UXN0193

subject_name: Methoxy polyethylene glycol-epoetin beta

object_name: chronic kidney disease


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: acute kidney failure


subject: CHEBI:192614

object_name: Acute Kidney Injury, CTCAE


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Parkinson disease


subject: UMLS:C4519575

subject_name: glecaprevir / pibrentasvir

object_name: hepatitis C


subject: UMLS:C4519575

object_name: pregnancy disorder


subject: UNII:MG7D3QD743

subject_name: Atiprimod

object_name: Advanced cancer


subject: CHEBI:6538

subject_name: Loratadine

object_name: Hay fever


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: venous thromboembolism


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:90919

subject_name: Technivie

object_name: chronic hepatitis C virus infection


subject: UMLS:C3864967

subject_name: ombitasvir / paritaprevir / ritonavir


subject: CHEBI:50249

subject_name: anticoagulant

object_name: stroke disorder


subject: CHEBI:50249

object_name: cerebrovascular disorder


subject: CHEBI:50249

object_name: Stroke (heart beat)


subject: CHEBI:50249

object_name: Stroke, CTCAE


subject: CHEBI:50249

object_name: cervical artery dissection


subject: CHEBI:50249

object_name: vertebral artery dissection


subject: CHEBI:50249

object_name: carotid artery dissection


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C3536711

subject_name: Anti-coagulant [EPC]


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C3536711


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]


subject: UMLS:C2825026


subject: UMLS:C2825026


subject: UMLS:C2825026


subject: UMLS:C2825026


subject: UMLS:C2825026


subject: UMLS:C2825026


subject: PUBCHEM.COMPOUND:25244225

subject_name: Lmw heparin


subject: PUBCHEM.COMPOUND:25244225


subject: PUBCHEM.COMPOUND:25244225


subject: PUBCHEM.COMPOUND:25244225


subject: PUBCHEM.COMPOUND:25244225


subject: PUBCHEM.COMPOUND:25244225


subject: PUBCHEM.COMPOUND:25244225


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight


subject: MESH:D006495


subject: MESH:D006495


subject: MESH:D006495


subject: MESH:D006495


subject: MESH:D006495


subject: MESH:D006495


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: CHEBI:10033


subject: UMLS:C5214487

subject_name: Antiplatelet


subject: UMLS:C5214487


subject: UMLS:C5214487


subject: UMLS:C5214487


subject: UMLS:C5214487


subject: UMLS:C5214487


subject: UMLS:C5214487


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:4653

subject_name: Dipyridamole


subject: CHEBI:4653


subject: CHEBI:4653


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941


subject: CHEBI:37941


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:6456

subject_name: Lidocaine

object_name: wrist fracture


subject: CHEBI:6456

object_name: Fractured carpal bone


subject: CHEBI:6456

object_name: Wrist Fracture, CTCAE


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:3032

subject_name: Benzonatate

object_name: Cough


subject: CHEBI:3032

object_name: Cough, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: breast cancer


subject: UMLS:C3177463

subject_name: etrolizumab

object_name: ulcerative colitis


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Non-clear cell renal cell carcinoma


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:151315

object_name: brain aneurysm


subject: CHEBI:230519

subject_name: heparin sodium


subject: UMLS:C0077503

subject_name: Tumor Necrosis Factor Receptor

object_name: asthma


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: HIV infection


subject: UNII:PP0SHH6V16

object_name: cardiovascular disorder


subject: UNII:PP0SHH6V16

object_name: Dyslipidemia


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Hypercholesterolemia


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UMLS:C3713322

object_name: hepatitis C


subject: UMLS:C2699335

subject_name: cixutumumab

object_name: rectal carcinoma


subject: UMLS:C2699335

object_name: rectal cancer


subject: UMLS:C2699335

object_name: Childhood Rectal Carcinoma


subject: UMLS:C2699335

object_name: colon carcinoma


subject: UMLS:C2699335

object_name: colorectal cancer


subject: UMLS:C2699335

object_name: colon cancer


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:82960

subject_name: Raltegravir

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:82960

object_name: metabolic syndrome X


subject: CHEBI:82960

object_name: Fatty Liver


subject: CHEBI:82960

object_name: Human Immunodeficiency Virus Positive


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: EGFR Gene Amplification


subject: PUBCHEM.COMPOUND:70789204

object_name: HER2 gene amplification


subject: PUBCHEM.COMPOUND:70789204

object_name: ERBB2 Gene Mutation


subject: PUBCHEM.COMPOUND:70789204

object_name: ERBB3 Gene Mutation


subject: PUBCHEM.COMPOUND:70789204

object_name: ERBB4 Gene Mutation


subject: PUBCHEM.COMPOUND:70789204

object_name: EGFR gene mutation


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:70789204

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:70789204

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:61397

subject_name: Neratinib


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:9907

subject_name: ursodiol

object_name: end stage renal failure


subject: CHEBI:9907

object_name: Chronic uremia


subject: MESH:D006170

subject_name: Gum Arabic

object_name: ulcerative colitis


subject: MESH:D006170

object_name: inflammatory bowel disease 1


subject: UMLS:C2093618

subject_name: arabic gum allergenic extract


subject: UMLS:C2093618


subject: DRUGBANK:DB10451

subject_name: Acacia


subject: DRUGBANK:DB10451


subject: CHEBI:167997

subject_name: Cellulose, microcrystalline


subject: CHEBI:167997


subject: CHEBI:62968

subject_name: Microcrystalline cellulose


subject: CHEBI:62968


subject: CHEBI:87715

subject_name: Prasugrel

object_name: cardiovascular disorder


subject: CHEBI:87715

object_name: myocardial ischemia


subject: UMLS:C5238974

object_name: Childhood Solid Neoplasm


subject: UMLS:C5238974

object_name: Adult Solid Neoplasm


subject: UMLS:C5238974

object_name: Solid Neoplasm


subject: UNII:0IN1TZ844E

subject_name: ZELENECTIDE PEVEDOTIN

object_name: non-small cell lung carcinoma


subject: UMLS:C5555005

subject_name: Zelenectide Pevedotin


subject: GTOPDB:13769

subject_name: retatrutide

object_name: obstructive sleep apnea syndrome


subject: CHEMBL.COMPOUND:CHEMBL5095485

subject_name: RETATRUTIDE


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: alopecia areata


subject: CHEBI:50749

object_name: alopecia


subject: CHEBI:91872

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:231347

subject_name: Triapine


subject: CHEBI:177570

subject_name: Deslorelin

object_name: hereditary endocrine growth disease


subject: CHEBI:177570

object_name: Dwarfism


subject: CHEBI:601027

subject_name: Aliskiren

object_name: abdominal aortic aneurysm


subject: CHEBI:601027

object_name: aortic aneurysm, familial abdominal, 1


subject: UMLS:C3852582

object_name: type 2 diabetes mellitus


subject: CHEBI:5613

subject_name: Haloperidol

object_name: mood disorder


subject: CHEBI:10119

subject_name: Ziprasidone


subject: PUBCHEM.COMPOUND:46874763

object_name: Antibiotic resistant infection


subject: UMLS:C0003232

subject_name: Antibiotics


subject: MESH:C066069

subject_name: Padma 28

object_name: coronary artery disorder


subject: MESH:C066069

object_name: coronary atherosclerosis


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: acute pancreatitis


subject: UMLS:C0596581

subject_name: Fluoropyrimidine

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:45934446

subject_name: Licochalcone A

object_name: squamous cell carcinoma


subject: UMLS:C4547427

subject_name: (18F)T807 compound

object_name: Alzheimer disease type 1


subject: UMLS:C4547427

object_name: Alzheimer disease


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Myoclonus


subject: CHEBI:44241

subject_name: Metyrapone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:44241

object_name: obesity


subject: CHEBI:44241

object_name: Obesity, CTCAE


subject: CHEBI:44241

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:44241

object_name: metabolic syndrome X


subject: CHEBI:44241


subject: CHEBI:44241

object_name: Insulin resistance


subject: CHEBI:29033

subject_name: Ferrous cation


subject: CHEBI:29033


subject: CHEBI:29033


subject: CHEBI:29033


subject: CHEBI:29033


subject: CHEBI:29033

object_name: type 2 diabetes mellitus


subject: CHEBI:29033


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Hemodynamic instability


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: colon cancer


subject: UMLS:C0085297

object_name: malignant urinary system neoplasm


subject: UMLS:C0085297

object_name: melanoma


subject: UMLS:C0879283

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C0879283

object_name: non-Hodgkin lymphoma


subject: UMLS:C0879283

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C0879283

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0879283

object_name: follicular lymphoma


subject: CHEBI:44915

subject_name: Propofol

object_name: spinal disease


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: UNII:EO144CP0X9

subject_name: Avalglucosidase alfa

object_name: glycogen storage disease II


subject: UMLS:C3274916

subject_name: GRASPA

object_name: acute lymphoblastic leukemia


subject: UMLS:C1872017

subject_name: depatuxizumab

object_name: esophageal adenocarcinoma


subject: UMLS:C1872017

object_name: lung adenocarcinoma


subject: UMLS:C1872017

object_name: cervical adenocarcinoma


subject: UMLS:C1872017

object_name: adenocarcinoma


subject: UMLS:C1872017

object_name: bile duct adenocarcinoma


subject: UMLS:C1872017

object_name: gastric adenocarcinoma


subject: GTOPDB:11278

subject_name: bemarituzumab


subject: GTOPDB:11278


subject: GTOPDB:11278


subject: GTOPDB:11278


subject: GTOPDB:11278


subject: GTOPDB:11278


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: MESH:C560489

subject_name: MVA vaccine

object_name: monkey disease


subject: MESH:C560489

object_name: monkeypox


subject: CHEBI:31547

subject_name: Eplerenone

object_name: cardiomyopathy


subject: CHEBI:35469

subject_name: antidepressant

object_name: Depressed mood


subject: CHEBI:35469

object_name: Cancer patients and suicide and depression


subject: CHEBI:35469

object_name: Depressed - symptom


subject: CHEBI:35469

object_name: Depression, CTCAE


subject: CHEBI:35469

object_name: sleep disorder, initiating and maintaining sleep


subject: CHEBI:35469

object_name: insomnia


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: UMLS:C0003289


subject: UMLS:C0003289


subject: UMLS:C0003289


subject: UMLS:C0003289


subject: UMLS:C0003289


subject: CHEBI:16349

subject_name: Citrulline

object_name: Arterial Stiffness


subject: CHEBI:16349

object_name: Adolescent Obesity


subject: CHEBI:16349

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT

object_name: Fatigue, CTCAE 5.0


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: Fatigue


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: precancerous condition


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: unspecified adult solid tumor, protocol specific


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: myeloproliferative neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: pediatric lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: leukemia


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: childhood leukemia


subject: CHEBI:6015

subject_name: Isoflurane

object_name: hepatobiliary disorder


subject: CHEBI:6015

object_name: liver disorder


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: cardiac arrest


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: CHEBI:32696


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:229643

subject_name: Zavegepant

object_name: migraine


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: hereditary leiomyomatosis and renal cell cancer


subject: UNII:52CMI0WC3Y

object_name: Multiple cutaneous leiomyomas


subject: UNII:52CMI0WC3Y

object_name: papillary renal cell carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:114785

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:114785

object_name: clear cell renal carcinoma


subject: CHEBI:114785

object_name: renal cell adenocarcinoma


subject: CHEBI:114785

object_name: renal cell carcinoma


subject: CHEBI:114785


subject: UMLS:C2713110

subject_name: SODIUM FLUORIDE F-18, DIAGNOSTIC, PER STUDY DOSE, UP TO 30 MILLICURIES


subject: UMLS:C2713110


subject: UMLS:C2713110


subject: UMLS:C2713110


subject: UMLS:C2713110


subject: UMLS:C2713110


subject: UMLS:C2713110


subject: UMLS:C2713110


subject: UMLS:C2713110


subject: CHEBI:28741

subject_name: Sodium fluoride


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:28741


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Diabetes


subject: CHEBI:85078

object_name: diabetes mellitus


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Lennox-Gastaut syndrome


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic Ewing's Sarcoma


subject: CHEBI:72317

object_name: Unresectable Ewing Sarcoma


subject: CHEBI:72317

object_name: Unresectable Osteosarcoma


subject: CHEBI:72317

object_name: Stage IV Osteosarcoma AJCC v7


subject: CHEBI:72317

object_name: Stage III Osteosarcoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVA Osteosarcoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVB Osteosarcoma AJCC v7


subject: CHEBI:17606

subject_name: Iodine

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: filarial elephantiasis


subject: CHEBI:6078

subject_name: Ivermectin


subject: UMLS:C2937463

subject_name: PERFLUTREN 6.52 mg in 1 mL INTRAVENOUS INJECTION, SUSPENSION [Definity]

object_name: pancreatitis


subject: UMLS:C2937463

object_name: Insulitis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: medical induction of labor affecting fetus


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C3535674

subject_name: Pea Proteins

object_name: Ileostomy - stoma


subject: UNII:4ADT8JXB9S

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4045791


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: hypertriglyceridemia


subject: UMLS:C3714501

object_name: Hypertriglyceridemia, CTCAE


subject: UMLS:C3714501

object_name: acute pancreatitis


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:4702

subject_name: Dorzolamide

object_name: ocular hypertension


subject: CHEBI:4702

object_name: Ocular hypertension


subject: CHEBI:4702

object_name: OPTN-related open angle glaucoma


subject: CHEBI:4702

object_name: open-angle glaucoma


subject: CHEBI:22587

subject_name: antiviral agent

object_name: hepatitis C


subject: UMLS:C0003451

subject_name: Antiviral Agents


subject: CHEBI:4445

subject_name: Desflurane

object_name: pituitary tumor


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Caesarean section


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:32682

subject_name: L-argininium

object_name: type 2 diabetes mellitus


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: UMLS:C5854613

subject_name: TIGIT/PD-L1 Inhibitor AUR-106

object_name: Recurrent disease


subject: UMLS:C5854613

object_name: Global Relapse in Viscera


subject: UMLS:C5854613

object_name: Global Relapse in Lymph Nodes


subject: UMLS:C5854613

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UMLS:C5854613

object_name: Global Relapse


subject: UMLS:C5854613

object_name: Global Relapse in Skin


subject: UMLS:C5854613

object_name: Global Relapse in Blood


subject: UMLS:C5854613

object_name: Advanced cancer


subject: UMLS:C5854613

object_name: non-small cell lung carcinoma


subject: UMLS:C5854613

object_name: urothelial carcinoma


subject: UMLS:C5854613

object_name: transitional cell carcinoma


subject: UMLS:C5854613

object_name: esophageal cancer


subject: UMLS:C5854613

object_name: Stomach cancer


subject: UMLS:C5854613

object_name: gastric cancer


subject: UMLS:C5854613

object_name: renal carcinoma


subject: UMLS:C5854613

object_name: kidney neoplasm


subject: UMLS:C5854613

object_name: kidney cancer


subject: UMLS:C5854613

object_name: colon carcinoma


subject: UMLS:C5854613

object_name: colorectal cancer


subject: UMLS:C5854613

object_name: colon cancer


subject: UMLS:C5774089

subject_name: VIGIV

object_name: Complication of smallpox vaccination


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17754

subject_name: Glycerin


subject: CHEBI:17754

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:17754

object_name: obesity


subject: CHEBI:17754

object_name: Obesity, CTCAE


subject: CHEBI:24996

subject_name: lactate


subject: CHEBI:24996


subject: CHEBI:24996


subject: CHEBI:24996


subject: CHEBI:42111

subject_name: D-Lactic acid


subject: CHEBI:42111


subject: CHEBI:42111


subject: CHEBI:42111


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411


subject: CHEBI:16411


subject: CHEBI:16411


subject: MESH:D007773

subject_name: Lactates


subject: MESH:D007773


subject: MESH:D007773


subject: MESH:D007773


subject: CHEBI:78320

subject_name: Lactic acid


subject: CHEBI:78320


subject: CHEBI:78320


subject: CHEBI:78320


subject: GTOPDB:8931

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297556


subject: UMLS:C2827711


subject: UNII:571LVA9UMS

subject_name: Telatinib Mesylate

object_name: Adult Solid Neoplasm


subject: UMLS:C2981421


subject: CHEBI:5959

subject_name: Irbesartan

object_name: IgA Nephropathy


subject: CHEBI:73612

subject_name: Met-Pro


subject: UNII:BE9PTC7J7P

subject_name: MP


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:135572

subject_name: Prednylidene


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: aspergillosis


subject: UMLS:C0532508


subject: CHEBI:10023

subject_name: Voriconazole


subject: CHEBI:59527

object_name: rheumatoid arthritis


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UMLS:C0068161

subject_name: N-monoacetylcystine

object_name: Cooley's anemia


subject: UMLS:C0068161

object_name: beta thalassemia


subject: CHEBI:9168

subject_name: Sirolimus

object_name: uveitis


subject: CHEBI:9168

object_name: Uveitis, CTCAE


subject: CHEBI:9168

object_name: panuveitis


subject: CHEBI:9168

object_name: choroiditis


subject: CHEBI:9168

object_name: posterior uveitis


subject: CHEBI:9168

object_name: intermediate uveitis


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: mood (physical finding)


subject: UMLS:C0301532

object_name: outcomes general quality of life


subject: UMLS:C0301532

object_name: Perceived quality of life


subject: UMLS:C0301532

object_name: Good quality of life


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: respiratory system disorder


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: essential hypertension


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:63632

subject_name: Topotecan

object_name: malignant soft tissue neoplasm


subject: CHEBI:63632

object_name: sarcoma


subject: CHEBI:31270

subject_name: beraprost sodium

object_name: kidney failure


subject: PUBCHEM.COMPOUND:2352

subject_name: beraprost


subject: UMLS:C0526064


subject: UMLS:C2740858

subject_name: BPS


subject: UMLS:C2756343

subject_name: Mirapex ER

object_name: Parkinson disease


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: Menopause present (finding)


subject: CHEBI:5778

object_name: Menopause


subject: CHEBI:5778

object_name: Hyperuricemia


subject: CHEBI:5778

object_name: Hyperuricemia, CTCAE


subject: CHEBI:8024

subject_name: Perindopril


subject: CHEBI:8024


subject: CHEBI:8024


subject: CHEBI:8024


subject: UMLS:C1519138

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C1519138

object_name: non-Hodgkin lymphoma


subject: UMLS:C1519138

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C1519138

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4547475

object_name: pneumonitis


subject: UMLS:C4547475

object_name: pneumonia


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Childhood Breast Carcinoma


subject: GTOPDB:8313

object_name: breast carcinoma


subject: GTOPDB:8313

object_name: breast cancer


subject: PUBCHEM.COMPOUND:10752953


subject: PUBCHEM.COMPOUND:10752953


subject: PUBCHEM.COMPOUND:10752953


subject: CHEBI:50182

subject_name: ARUNDINE


subject: CHEBI:50182


subject: CHEBI:50182


subject: UMLS:C0114346

subject_name: Dimesna


subject: UMLS:C0114346


subject: UMLS:C0114346


subject: CHEBI:32139

object_name: diabetes mellitus


subject: CHEBI:32139

object_name: Chronic uremia


subject: CHEBI:184023

subject_name: Argininosuccinic acid

object_name: short chain acyl-CoA dehydrogenase deficiency


subject: CHEBI:184023

object_name: idiopathic spontaneous coronary artery dissection


subject: CHEBI:184023

object_name: anterolateral myocardial infarction


subject: CHEBI:184023

object_name: myocardial infarction


subject: CHEBI:184023

object_name: acute myocardial infarction


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:135207


subject: CHEBI:135207


subject: CHEBI:135207


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:15365


subject: PR:000004321

subject_name: arylsulfatase A


subject: PR:000004321


subject: PR:000004321


subject: PR:000004321


subject: PR:000004321


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941


subject: CHEBI:37941


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate


subject: CHEBI:85974


subject: CHEBI:85974


subject: CHEBI:85974


subject: CHEBI:85974


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON

object_name: Glucagon resistance


subject: CHEMBL.COMPOUND:CHEMBL5314341

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:5391

subject_name: Glucagon


subject: CHEBI:5391


subject: CHEBI:71940

subject_name: Tadalafil

object_name: aortic stenosis


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: invasive tubular breast carcinoma


subject: UMLS:C1518041

object_name: Mucinous breast cancer


subject: UMLS:C1518041

object_name: breast mucinous carcinoma


subject: UMLS:C1518041

object_name: inflammatory breast carcinoma


subject: UMLS:C1518041

object_name: invasive ductal breast carcinoma


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:180856

subject_name: Hovenoside G

object_name: renal cell carcinoma


subject: CHEBI:180856

object_name: kidney cancer


subject: CHEBI:180856

object_name: kidney neoplasm


subject: CHEBI:16664

subject_name: Albendazole

object_name: filarial; infestation


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Adult Acute Leukemia in Remission


subject: PUBCHEM.COMPOUND:155543961

object_name: Childhood Acute Leukemia in Remission


subject: PUBCHEM.COMPOUND:155543961

object_name: Acute leukemia in remission


subject: PUBCHEM.COMPOUND:155543961

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:155543961

object_name: obesity due to congenital leptin deficiency


subject: PUBCHEM.COMPOUND:155543961

object_name: obesity due to leptin receptor gene deficiency


subject: PUBCHEM.COMPOUND:155543961

object_name: morbid obesity


subject: PUBCHEM.COMPOUND:155543961

object_name: long COVID-19


subject: PUBCHEM.COMPOUND:155543961

object_name: Chronic post-COVID-19 syndrome


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Childhood Gastrointestinal Stromal Tumor


subject: UMLS:C1567379

object_name: Plexosarcoma


subject: UMLS:C1567379


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: adult acute myeloid leukemia


subject: CHEBI:91397

object_name: childhood acute myeloid leukemia


subject: CHEBI:91397

object_name: acute myeloid leukemia


subject: CHEBI:33704

subject_name: Amino acid

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: CHEMBL.COMPOUND:CHEMBL5095484

subject_name: REMTERNETUG

object_name: Alzheimer disease


subject: UMLS:C5783906

subject_name: Remternetug


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PUBCHEM.COMPOUND:521267

subject_name: (R)-Carvotanacetone

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:521267

object_name: prostate cancer


subject: CHEBI:50742

subject_name: cyproterone


subject: CHEBI:50742


subject: UMLS:C0699709

subject_name: Androcur


subject: UMLS:C0699709


subject: KEGG.COMPOUND:C00816

subject_name: Collagenase

object_name: familial Dupuytren contracture


subject: KEGG.COMPOUND:C00816

object_name: palmar fibromatosis


subject: KEGG.COMPOUND:C00816

object_name: Dupuytren's contracture (physical finding)


subject: UNII:9X7O8V25IT

subject_name: collagenase


subject: UNII:9X7O8V25IT


subject: UNII:9X7O8V25IT


subject: UMLS:C3713322

object_name: chronic hepatitis C virus infection


subject: UMLS:C2703114

object_name: liver carcinoma


subject: CHEBI:184472

subject_name: Nitrofurantoin

object_name: Recurrent urinary tract infections


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: urothelial carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: transitional cell carcinoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872

object_name: bladder tumor


subject: CHEBI:91872

object_name: urinary bladder carcinoma


subject: CHEBI:91872

object_name: urinary bladder cancer


subject: CHEBI:91872

object_name: childhood bladder carcinoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: inflammatory bowel disease


subject: CHEBI:135207

subject_name: Clofedanol

object_name: pharyngitis


subject: CHEBI:135207

object_name: Pharyngitis, CTCAE


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: UMLS:C4549686

object_name: diabetic kidney disease


subject: CHEBI:17596

subject_name: Inosine

object_name: pulmonary fibrosis


subject: CHEBI:17596

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:17596

object_name: pulmonary hypertension


subject: CHEBI:17596

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:17596

object_name: pulmonary sarcoidosis


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411


subject: CHEBI:16411


subject: CHEBI:16411


subject: CHEBI:16411


subject: UMLS:C3641657

subject_name: CEND 1

object_name: Metastatic malignant neoplasm to peritoneum


subject: UMLS:C3641657

object_name: colorectal cancer


subject: UMLS:C3641657

object_name: colorectal carcinoma


subject: UMLS:C3641657

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3641657

object_name: appendix cancer


subject: UMLS:C3641657

object_name: appendix carcinoma


subject: UMLS:C3641657

object_name: ovarian cancer


subject: UMLS:C3641657

object_name: ovarian carcinoma


subject: UMLS:C3641657

object_name: malignant epithelial tumor of ovary


subject: PR:000001089

subject_name: immunoglobulin superfamily member 2

object_name: tuberculosis


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Carcinoma breast stage IV


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: pterygium


subject: UNII:ZL1R02VT79

object_name: conjunctival pterygium


subject: CHEBI:7575

subject_name: Nimodipine

object_name: stroke disorder


subject: CHEBI:7575

object_name: cerebral infarction


subject: CHEBI:7575

object_name: cerebrovascular disorder


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:49086


subject: CHEBI:16436

subject_name: Citicoline


subject: UNII:6897GXD6OE

object_name: Altitude Hypoxia


subject: UNII:6897GXD6OE

object_name: Pulmonary vascular resistance abnormality


subject: CHEBI:91329

object_name: malignant glioma


subject: CHEBI:91329

object_name: brain stem glioma


subject: CHEBI:91329

object_name: Childhood Anaplastic Oligodendroglioma


subject: CHEBI:91329

object_name: anaplastic oligodendroglioma


subject: CHEBI:91329

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:91329

object_name: glioblastoma


subject: CHEBI:91329

object_name: Brain Stem Glioblastoma


subject: CHEBI:91329

object_name: glioma susceptibility 1


subject: CHEBI:91329

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:91329

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:91329

object_name: anaplastic astrocytoma


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: UMLS:C2703143


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Acute Stroke Related to COVID-19


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: metastatic prostate carcinoma


subject: CHEBI:63584

object_name: Metastatic Prostate Neuroendocrine Carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:44915

subject_name: Propofol

object_name: Complication of hemodialysis


subject: CHEBI:44915

object_name: end stage renal failure


subject: CHEBI:44915

object_name: Chronic uremia


subject: UMLS:C1328138

object_name: T-Cell Lymphoma


subject: CHEBI:49668

subject_name: Gefitinib

object_name: breast neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5095378

subject_name: ENGLUMAFUSP ALFA

object_name: lymphoma, non-Hodgkin, familial


subject: CHEMBL.COMPOUND:CHEMBL5095378

object_name: non-Hodgkin lymphoma


subject: UMLS:C5706664

subject_name: Englumafusp alfa


subject: UMLS:C5706664


subject: UNII:06P3KLK2J8

subject_name: Glofitamab


subject: UNII:06P3KLK2J8


subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C4725069


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: Uses contraception (finding)


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:2549

subject_name: Albuterol

object_name: primary ciliary dyskinesia


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: Heart failure with normal ejection fraction


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: plasma cell myeloma


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: Anorexia


subject: UNII:3VHF2ZD92J

object_name: eating disorder


subject: UNII:950O97NUPO

subject_name: Preladenant

object_name: drug-induced akathisia


subject: UNII:950O97NUPO

object_name: movement disorder


subject: CHEBI:3077

subject_name: Betamethasone

object_name: myopia


subject: CHEBI:3077

object_name: corneal disease


subject: CHEBI:3077

object_name: hyperopia


subject: CHEBI:3077

object_name: pterygium


subject: CHEBI:3077

object_name: conjunctival pterygium


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: UNII:6GNT3Y5LMF


subject: UNII:6GNT3Y5LMF


subject: UNII:6GNT3Y5LMF


subject: UNII:6GNT3Y5LMF


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: UMLS:C4053753

subject_name: tetravalent RNA-lipoplex cancer vaccine

object_name: melanoma


subject: CHEBI:58097

object_name: pain agnosia


subject: CHEBI:58097

object_name: Pain insensitivity


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Premature infant


subject: CHEBI:81579

subject_name: Erythropoietin


subject: GTOPDB:10752

subject_name: leronlimab


subject: CHEMBL.COMPOUND:CHEMBL2109343

subject_name: LERONLIMAB


subject: UMLS:C3179325

subject_name: PRO 140


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: esophageal adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: lung adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: cervical adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: bile duct adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109402

object_name: gastric adenocarcinoma


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: UMLS:C2703144


subject: GTOPDB:9589

subject_name: enoblituzumab

object_name: peritoneum cancer


subject: GTOPDB:9589

object_name: cancer


subject: GTOPDB:9589

object_name: neoplasm


subject: GTOPDB:9589

object_name: fallopian tube carcinoma


subject: GTOPDB:9589

object_name: fallopian tube cancer


subject: GTOPDB:9589

object_name: ovarian cancer


subject: GTOPDB:9589

object_name: ovarian neoplasm


subject: GTOPDB:9589

object_name: ovarian carcinoma


subject: GTOPDB:9589

object_name: Childhood Solid Neoplasm


subject: GTOPDB:9589

object_name: Adult Solid Neoplasm


subject: GTOPDB:9589

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3545373

subject_name: ENOBLITUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: MESH:C000592697

subject_name: rellidep

object_name: Depressed mood


subject: MESH:C000592697

object_name: Cancer patients and suicide and depression


subject: MESH:C000592697

object_name: Depressed - symptom


subject: MESH:C000592697

object_name: Depression, CTCAE


subject: UMLS:C3827061

object_name: melanoma


subject: CHEBI:167672

subject_name: Tovorafenib


subject: UNII:9RV78Q2002

subject_name: Vedolizumab


subject: UMLS:C1098513


subject: CHEBI:135910

subject_name: Ganirelix

object_name: paroxysmal familial ventricular fibrillation


subject: CHEBI:135910

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: UMLS:C0872894

subject_name: ganirelix acetate


subject: UMLS:C0872894


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: Metastatic malignant neoplasm to liver


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:9839867

subject_name: Disodium EDTA

object_name: Rest limb pain


subject: PUBCHEM.COMPOUND:9839867

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:9839867

object_name: peripheral arterial disease


subject: CHEBI:4735

subject_name: Edetic acid


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:63613

subject_name: Nevirapine

object_name: Insulin Sensitivity


subject: CHEBI:63613

object_name: diabetes mellitus


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: gastroenteritis


subject: UNII:1Z08G7438A

subject_name: Dovramilast

object_name: Erythema nodosum leprosum


subject: UNII:1Z08G7438A

object_name: Type 2 lepra reaction


subject: CHEBI:4672

subject_name: Docetaxel

object_name: urinary bladder carcinoma


subject: CHEBI:4672

object_name: urinary bladder cancer


subject: CHEBI:4672

object_name: childhood bladder carcinoma


subject: CHEBI:6704

subject_name: Mebendazole

object_name: Necatoriasis due to Necator americanus (disorder)


subject: CHEBI:6704

object_name: Ancylostomiasis due to Ancylostoma ceylonicum (disorder)


subject: UNII:4B3SC438HI

subject_name: METHYLPHENIDATE HYDROCHLORIDE

object_name: Fatigue, CTCAE 5.0


subject: UNII:4B3SC438HI

object_name: Fatigue


subject: UNII:4B3SC438HI

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: leukemia


subject: CHEBI:3770

object_name: childhood leukemia


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: RXCUI:151399

subject_name: Bactrim


subject: RXCUI:151399


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:64677


subject: CHEBI:64816


subject: CHEBI:64816


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: anxiety


subject: UMLS:C1527137

object_name: Anxiety symptoms


subject: UMLS:C1527137

object_name: Anxiety, CTCAE 3.0


subject: UMLS:C1527137

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: HMDB:HMDB0015332

subject_name: Rifapentine

object_name: opiate dependence


subject: HMDB:HMDB0015332

object_name: Addiction


subject: HMDB:HMDB0015332

object_name: hepatitis A


subject: HMDB:HMDB0015332

object_name: hepatitis


subject: HMDB:HMDB0015332

object_name: AIDS


subject: MESH:D002214

subject_name: Capsules

object_name: attention deficit hyperactivity disorder, inattentive type


subject: MESH:D002214


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: pulmonary embolism


subject: CHEBI:70839

subject_name: Dasatinib

object_name: schizophrenia


subject: CHEBI:70839

object_name: treatment resistant depression


subject: CHEBI:70839


subject: CHEBI:70839

object_name: premature aging syndrome


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:16243


subject: CHEBI:16243


subject: UMLS:C3900049

object_name: essential thrombocythemia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Carcinoma breast stage IV


subject: UMLS:C0083036

object_name: common variable immunodeficiency


subject: UMLS:C0083036

object_name: Acquired Hypogammaglobulinemia


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: Axial Spondyloarthritis


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Breast cancer recurrent


subject: UNII:L08J2O299M

subject_name: Taselisib


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: prostate adenocarcinoma


subject: UNII:P76B05O5V6

subject_name: Relugolix


subject: MESH:C000709231

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5854335

object_name: melanoma


subject: CHEBI:32150

object_name: kidney failure


subject: CHEBI:32150

object_name: Renal Failure, CTCAE


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:167309

subject_name: Methadone

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: periodontitis


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: tuberculosis


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:119486

subject_name: Efavirenz


subject: UNII:1EF190B6M7

subject_name: PLASMINOGEN

object_name: hypoplasminogenemia


subject: UNII:1EF190B6M7

object_name: Decreased level of plasminogen


subject: CHEBI:31348

subject_name: Capecitabine

object_name: stage IVA rectal cancer


subject: CHEBI:31348

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:31348

object_name: stage IVB rectal cancer


subject: CHEBI:31348

object_name: stage IVB colon cancer


subject: CHEBI:31348

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:31348

object_name: stage IVA colon cancer


subject: CHEBI:31348

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:31348

object_name: Colon cancer recurrent


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423

object_name: Recurrent Rectal Cancer


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: UNII:5M691HL4BO

subject_name: glatiramer acetate

object_name: multiple sclerosis


subject: CHEBI:74073

subject_name: Ile-Met


subject: CHEBI:30366

subject_name: imidazolide


subject: UMLS:C4733574

object_name: rheumatoid arthritis


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:31355

subject_name: Carboplatin

object_name: oropharynx squamous cell carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: non-Hodgkin lymphoma


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: CHEBI:47458

subject_name: Saracatinib

object_name: myositis ossificans


subject: CHEBI:47458

object_name: fibrodysplasia ossificans progressiva


subject: UMLS:C2987006

subject_name: saracatinib difumerate


subject: UMLS:C2987006


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: Klatskin Tumor


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:17026

subject_name: Progesterone

object_name: Anorexia


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: psoriasis


subject: CHEBI:17026

object_name: paroxysmal familial ventricular fibrillation


subject: CHEBI:17026

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: CHEBI:17026

object_name: infertility


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Neonatal disorder


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Unresectable Solid Neoplasm


subject: UMLS:C2346820


subject: CHEBI:94366

subject_name: itraconazole

object_name: Chronic pulmonary aspergillosis


subject: CHEBI:187893

subject_name: Baclofen

object_name: opiate dependence


subject: CHEBI:229539

subject_name: Durlobactam

object_name: VABP


subject: CHEBI:229539

object_name: bacteriemia


subject: CHEBI:229539

object_name: Bacteremia, CTCAE


subject: PUBCHEM.COMPOUND:5316

subject_name: Sulbactam


subject: PUBCHEM.COMPOUND:5316


subject: PUBCHEM.COMPOUND:5316


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: salivary gland disorder


subject: CHEBI:100241

object_name: HIV infection


subject: CHEBI:100241

object_name: Benign lymphoepithelial lesion


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: Addiction


subject: CHEBI:63630

subject_name: Tolcapone


subject: UMLS:C2981846

object_name: diffuse large B-cell lymphoma


subject: UMLS:C2981846

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C2981846

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: Neurogenic detrusor overactivity


subject: CHEBI:144551

subject_name: Oxybutynin


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Recurrent Hepatocellular Carcinoma


subject: UNII:28X28X9OKV

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:28X28X9OKV

object_name: Recurrent Cancer of Gallbladder


subject: UNII:28X28X9OKV

object_name: Stage IV Hepatocellular Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Cholangiocarcinoma recurrent


subject: UNII:28X28X9OKV

object_name: Stage IVB Hepatocellular Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IVA Hepatocellular Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage III Hepatocellular Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIC Hepatocellular Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Unresectable Gallbladder Carcinoma


subject: UNII:28X28X9OKV

object_name: Gallbladder Adenocarcinoma, Biliary Type


subject: UNII:28X28X9OKV

object_name: Extrahepatic Bile Duct Adenocarcinoma, Biliary Type


subject: UNII:28X28X9OKV

object_name: Pancreatic carcinoma recurrent


subject: UNII:28X28X9OKV

object_name: Stage IV Gallbladder Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: stage IVA gallbladder cancer


subject: UNII:28X28X9OKV

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage III Gallbladder Cancer AJCC v7


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:28X28X9OKV

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3641122

object_name: Recurrent Hepatocellular Carcinoma


subject: UMLS:C3641122

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C3641122

object_name: Recurrent Cancer of Gallbladder


subject: UMLS:C3641122

object_name: Stage IV Hepatocellular Carcinoma AJCC v7


subject: UMLS:C3641122

object_name: Cholangiocarcinoma recurrent


subject: UMLS:C3641122

object_name: Stage IVB Hepatocellular Carcinoma AJCC v7


subject: UMLS:C3641122

object_name: Stage IVA Hepatocellular Carcinoma AJCC v7


subject: UMLS:C3641122

object_name: Stage III Hepatocellular Carcinoma AJCC v7


subject: UMLS:C3641122

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: UMLS:C3641122

object_name: Stage IIIC Hepatocellular Carcinoma AJCC v7


subject: UMLS:C3641122

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v7


subject: UMLS:C3641122

object_name: Unresectable Gallbladder Carcinoma


subject: UMLS:C3641122

object_name: Gallbladder Adenocarcinoma, Biliary Type


subject: UMLS:C3641122

object_name: Extrahepatic Bile Duct Adenocarcinoma, Biliary Type


subject: UMLS:C3641122

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C3641122

object_name: Stage IV Gallbladder Cancer AJCC v7


subject: UMLS:C3641122

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: UMLS:C3641122

object_name: stage IVA gallbladder cancer


subject: UMLS:C3641122

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: UMLS:C3641122

object_name: Stage III Gallbladder Cancer AJCC v7


subject: UMLS:C3641122


subject: UMLS:C3641122

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: UMLS:C3641122

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: UMLS:C3641122

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: UMLS:C3641122

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: UMLS:C3641122

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: UMLS:C3641122

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3641122

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: Recurrent Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:136924190

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:136924190

object_name: Recurrent Cancer of Gallbladder


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IV Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Cholangiocarcinoma recurrent


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IVB Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IVA Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage III Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IIIC Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Unresectable Gallbladder Carcinoma


subject: PUBCHEM.COMPOUND:136924190

object_name: Gallbladder Adenocarcinoma, Biliary Type


subject: PUBCHEM.COMPOUND:136924190

object_name: Extrahepatic Bile Duct Adenocarcinoma, Biliary Type


subject: PUBCHEM.COMPOUND:136924190

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IV Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: stage IVA gallbladder cancer


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage III Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:136924190


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Pancreatic carcinoma non-resectable


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: nephroblastoma


subject: CHEBI:6067

object_name: Wilms tumor


subject: CHEBI:6067

object_name: childhood kidney Wilms tumor


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:187893

object_name: Spasticity, CTCAE


subject: CHEBI:187893

object_name: cerebral palsy


subject: UNII:G2AE2VE07O

subject_name: Revefenacin

object_name: COPD exacerbation


subject: CHEBI:63081

subject_name: (S,S)-formoterol


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Effects of chemotherapy


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: UMLS:C4547392

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4547392

object_name: plasma cell myeloma


subject: UMLS:C4547392

object_name: non-Hodgkin lymphoma


subject: UMLS:C0282575

subject_name: Micronutrients

object_name: malnutrition


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: skin neoplasm


subject: UNII:6QVL057INT

object_name: SUBCUTANEOUS TUMOR


subject: UNII:6QVL057INT

object_name: Childhood Malignant Solid Neoplasm


subject: UNII:6QVL057INT

object_name: Malignant Solid Neoplasm


subject: UNII:6QVL057INT

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:6QVL057INT

object_name: Metastatic malignant neoplasm to soft tissues


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UNII:HEZ9892GNP

subject_name: TOLODODEKIN ALFA

object_name: Childhood Solid Neoplasm


subject: UNII:HEZ9892GNP

object_name: Adult Solid Neoplasm


subject: UNII:HEZ9892GNP

object_name: Solid Neoplasm


subject: UNII:HEZ9892GNP

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:HEZ9892GNP

object_name: skin squamous cell carcinoma


subject: UNII:HEZ9892GNP

object_name: cutaneous squamous cell carcinoma


subject: UNII:HEZ9892GNP


subject: UNII:HEZ9892GNP


subject: UNII:HEZ9892GNP


subject: UNII:HEZ9892GNP


subject: UNII:HEZ9892GNP


subject: UNII:HEZ9892GNP

object_name: non-small cell lung carcinoma


subject: UNII:HEZ9892GNP


subject: CHEBI:103981

object_name: Severe Sepsis


subject: UNII:7A055A9QRR

subject_name: talactoferrin alfa


subject: UMLS:C1872514


subject: PUBCHEM.COMPOUND:11993742

subject_name: Percocet

object_name: Post-Operative Pain


subject: CHEBI:7514

subject_name: Neostigmine

object_name: neurogenic bowel


subject: CHEBI:7514

object_name: spinal cord injury


subject: CHEBI:134724

subject_name: Ipragliflozin

object_name: type 1 diabetes mellitus 1


subject: CHEBI:134724

object_name: type 1 diabetes mellitus


subject: KEGG.COMPOUND:C02380

object_name: leukemia


subject: KEGG.COMPOUND:C02380

object_name: childhood leukemia


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Breast cancer stage II


subject: UNII:DPT0O3T46P

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:DPT0O3T46P

object_name: Breast cancer stage III


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: idiopathic epilepsy


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: methamphetamine dependence in remission


subject: CHEBI:127342

object_name: continuous methamphetamine dependence


subject: CHEBI:33283

subject_name: THIAMINE

object_name: major injury


subject: UMLS:C3714802

subject_name: Thiamine Drug Class

object_name: Sepsis


subject: UMLS:C3714802

object_name: Sepsis, CTCAE


subject: UMLS:C3714802


subject: CHEBI:18385

subject_name: Thiamine


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: osteoporosis


subject: UNII:3VHF2ZD92J

object_name: Encounter due to family history of osteoporosis


subject: UNII:3VHF2ZD92J

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:3VHF2ZD92J

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:3VHF2ZD92J

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:129627881

subject_name: Noac

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:129627881

object_name: cerebrovascular disorder


subject: PUBCHEM.COMPOUND:129627881

object_name: Stroke (heart beat)


subject: PUBCHEM.COMPOUND:129627881

object_name: Stroke, CTCAE


subject: CHEBI:231132

subject_name: N(4)-Oleylcytosine arabinoside


subject: CHEBI:231132


subject: CHEBI:231132


subject: CHEBI:231132


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant


subject: UMLS:C5552956


subject: UMLS:C5552956


subject: UMLS:C5552956


subject: UNII:L1Q2K5JYO8

subject_name: SUNVOZERTINIB

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB18925

subject_name: Sunvozertinib


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: small bowel Crohn disease


subject: MESH:D000087503

subject_name: mRNA Vaccines


subject: CHEBI:63627

subject_name: Tinidazole

object_name: Malaria, Vivax


subject: CHEBI:135935

subject_name: Tapentadol

object_name: pain agnosia


subject: CHEBI:135935

object_name: Pain insensitivity


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C1518573

subject_name: OncoVAX

object_name: Stage II Colon Cancer AJCC v8


subject: UMLS:C1518573

object_name: Stage II Colon Cancer AJCC v7


subject: UMLS:C1518573

object_name: Stage II Colon Cancer


subject: UNII:PFP09575EX

object_name: skin carcinoma


subject: PUBCHEM.COMPOUND:54201037

subject_name: Retinoid 9CUAB30


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: hairy cell leukemia


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4975

subject_name: Famotidine


subject: UNII:2NDX4B6N8F

subject_name: HA 22


subject: UMLS:C2346797


subject: UMLS:C4330528

object_name: small cell lung carcinoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: BK viraemia


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C3257589

subject_name: Live Vaccinia Virus Vaccine

object_name: smallpox


subject: UMLS:C5418138

subject_name: imvanex


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:231601

object_name: malignant neoplasm of breast stage I


subject: CHEBI:231601

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:231601

object_name: Carcinoma breast stage I


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: MESH:C000716088

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: PR:000008944

subject_name: insulin-like growth factor 2 mRNA-binding protein 2

object_name: Leg Ulcer


subject: PR:000008944

object_name: Varicose Ulcer


subject: PR:000008944

object_name: Foot Ulcer


subject: PR:000008944

object_name: ecthyma


subject: PR:000015566

subject_name: signal peptide peptidase-like 3


subject: PR:000015566


subject: PR:000015566


subject: PR:000015566


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: polyneuropathy


subject: CHEBI:64356

subject_name: Pregabalin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: neuralgia


subject: PUBCHEM.COMPOUND:43805

object_name: Neuropathic pain


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:74947

subject_name: Thalidomide

object_name: liver carcinoma


subject: CHEBI:32188

subject_name: Tegafur


subject: CHEBI:17568

subject_name: Uracil


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil


subject: UMLS:C5848289

subject_name: Ufur


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: Intracranial hemorrhage


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: plasma cell myeloma


subject: UMLS:C3827072


subject: UMLS:C0006217

subject_name: bromelains

object_name: pseudomyxoma peritonei


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine

object_name: Anemia, CTCAE


subject: UMLS:C3884847

subject_name: ma zi ren wan

object_name: Constipation


subject: UMLS:C3884847

object_name: Constipation, CTCAE


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Rectal cancer stage I


subject: UNII:1C6V77QF41

object_name: Stage I Rectal Cancer AJCC v6 and v7


subject: UNII:1C6V77QF41

object_name: Stage I Rectal Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Carcinoma of colon, stage I


subject: UNII:1C6V77QF41

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: UNII:1C6V77QF41

object_name: Stage I Colon Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: colon mucinous adenocarcinoma


subject: UNII:1C6V77QF41

object_name: colon signet ring cell adenocarcinoma


subject: UNII:1C6V77QF41

object_name: rectal signet ring cell adenocarcinoma


subject: UNII:1C6V77QF41

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:8988

object_name: Decreased liver function


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:23359

subject_name: colchicine

object_name: gout


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Infection


subject: CHEBI:3614

object_name: infectious disease


subject: CHEBI:3614

object_name: Adverse Event Associated with Infection


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:185135


subject: CHEBI:185135


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8347


subject: CHEBI:8347


subject: PUBCHEM.COMPOUND:11422859

object_name: acute myeloid leukemia, t(3;5)(q25;q34)


subject: PUBCHEM.COMPOUND:11422859

object_name: acute therapy-related myelogenous leukemia


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib


subject: PUBCHEM.COMPOUND:77256380


subject: UNII:7JNY4KV3NK

subject_name: OCIPERLIMAB

object_name: cervical cancer


subject: UNII:7JNY4KV3NK

object_name: cervical carcinoma


subject: UMLS:C5417829

subject_name: Ociperlimab


subject: UMLS:C5417829


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:3223

subject_name: Buspirone

object_name: Cannabis use disorder


subject: CHEBI:8871

subject_name: Risperidone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: autoimmune pulmonary alveolar proteinosis


subject: UNII:4F4X42SYQ6

object_name: pulmonary alveolar proteinosis


subject: UNII:4F4X42SYQ6

object_name: primary disorders


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:50692

subject_name: Mifepristone

object_name: BRCA1 gene mutation


subject: CHEBI:50692

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: bacterial infectious disease


subject: UNII:PI2EOQ4KE3

subject_name: LIATERMIN

object_name: Parkinson disease


subject: UMLS:C1527004

subject_name: Liatermin


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: focal epilepsy


subject: CHEBI:64356

subject_name: Pregabalin


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: UMLS:C0054066


subject: UMLS:C0054066


subject: UNII:4F4X42SYQ6

object_name: scleritis


subject: UNII:4F4X42SYQ6

object_name: orbital disease


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:174615

object_name: graft versus host disease


subject: CHEBI:174615

object_name: Plasma cell myeloma refractory


subject: CHEBI:174615

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:174615

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:174615

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: CHEBI:174615

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:174615

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:174615

object_name: marginal zone lymphoma


subject: CHEBI:174615

object_name: MALT lymphoma


subject: CHEBI:174615

object_name: follicular lymphoma


subject: CHEBI:174615

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: acute leukemia


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:28876

subject_name: Melphalan

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UMLS:C5854510

subject_name: Recombinant Albumin-binding IL-12 SON-1010

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C5854510

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4508905

object_name: Alzheimer disease


subject: UMLS:C1882164

subject_name: Oral Sodium Phenylbutyrate

object_name: lymphoproliferative syndrome


subject: UMLS:C1882164

object_name: adult lymphoma


subject: UMLS:C1882164

object_name: lymphoma


subject: UMLS:C1882164

object_name: pediatric lymphoma


subject: UMLS:C1882164

object_name: Stomach cancer


subject: UMLS:C1882164

object_name: gastric cancer


subject: UMLS:C1882164

object_name: Neck Carcinoma


subject: UMLS:C1882164

object_name: head and neck neoplasm


subject: UMLS:C1882164

object_name: head and neck cancer


subject: CHEBI:63635

subject_name: Valganciclovir


subject: CHEBI:63635


subject: CHEBI:63635


subject: CHEBI:63635


subject: CHEBI:63635


subject: CHEBI:63635


subject: CHEBI:63635


subject: CHEBI:63635


subject: CHEBI:63635


subject: CHEBI:17824

subject_name: isopropanol

object_name: Cleaning product causing toxic effect


subject: UNII:QH6B4V5743

subject_name: Rimeporide

object_name: Duchenne muscular dystrophy


subject: UMLS:C5206629

subject_name: Multi-kinase Inhibitor TT-00420

object_name: Metastatic cholangiocarcinoma


subject: UNII:WZ9TJ0L9Y8

subject_name: Tinengotinib


subject: UMLS:C4329337

subject_name: TAB 001

object_name: Muscle Invasive Bladder Carcinoma


subject: CHEBI:177770

subject_name: Ganetespib

object_name: plasma cell myeloma


subject: CHEBI:32599

object_name: Renal Colic, CTCAE


subject: CHEBI:32599

object_name: renal colic


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: retinal vein occlusion


subject: CHEBI:39548

object_name: Branch retinal vein occlusion


subject: CHEBI:39548

object_name: central retinal vein occlusion


subject: CHEBI:39548

object_name: Blood Clot


subject: CHEBI:39548

object_name: thrombosis


subject: CHEBI:39548

object_name: Thrombosis of blood vessel


subject: PUBCHEM.COMPOUND:2269

object_name: maxillary sinusitis


subject: CHEBI:2955

subject_name: Azithromycin


subject: UMLS:C1706082

subject_name: Compound (substance)


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:6801

subject_name: Metformin

object_name: glucose metabolism disease


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:93775

subject_name: Amethopterin

object_name: cancer


subject: CHEBI:93775

object_name: neoplasm


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5418074

subject_name: ADC MRG002

object_name: Locally Advanced Urothelial Carcinoma


subject: UMLS:C5418074

object_name: Metastatic urothelial carcinoma


subject: PR:000005931

object_name: chronic hepatitis B virus infection


subject: PR:000005931

object_name: hepatitis B


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:114785

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:114785

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:114785

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx